Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive Mechanistic View of the Hydrolysis of Oxadiazole-Based Inhibitors by Histone Deacetylase 6 (HDAC6)
L. Motlova, Ivan Šnajdr, Zsófia Kutil, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 7, pp. 1594-1610
Open Access | Times Cited: 11

Showing 11 citing articles:

Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase 6
Beate König, P. R. Watson, Nina Reßing, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 19, pp. 13821-13837
Open Access | Times Cited: 24
Selective and Bioavailable HDAC6 2-(Difluoromethyl)-1,3,4-oxadiazole Substrate Inhibitors and Modeling of Their Bioactivation Mechanism
Lena Ripa, Jenny Sandmark, Glyn A. Hughes, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 20, pp. 14188-14207
Closed Access | Times Cited: 15
Mechanistic and Structural Insights on Difluoromethyl-1,3,4-oxadiazole Inhibitors of HDAC6
Edoardo Cellupica, Aureliano Gaiassi, Ilaria Rocchio, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5885-5885
Open Access | Times Cited: 3
2-(Difluoromethyl)-1,3,4-oxadiazoles: The Future of Selective Histone Deacetylase 6 Modulation?
Beate König, Finn K. Hansen
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 3, pp. 899-903
Open Access | Times Cited: 2
Slow-Binding and Covalent HDAC Inhibition: A New Paradigm?
Yasir S. Raouf, Carlos Moreno–Yruela
JACS Au (2024) Vol. 4, Iss. 11, pp. 4148-4161
Open Access | Times Cited: 1
The Importance of the “Time Factor” for the Evaluation of Inhibition Mechanisms: The Case of Selected HDAC6 Inhibitors
Edoardo Cellupica, Gianluca Caprini, Gianluca Fossati, et al.
Biology (2023) Vol. 12, Iss. 8, pp. 1049-1049
Open Access | Times Cited: 3
Therapeutic indications for HDAC6 inhibitors in the peripheral and central nervous disorders
Jonathan van Eyll, Robert Prior, Sylvain Célanire, et al.
Expert Opinion on Therapeutic Targets (2024) Vol. 28, Iss. 9, pp. 719-737
Closed Access
Difluoromethyl-1,3,4-oxadiazoles are selective, mechanism-based, and essentially irreversible inhibitors of histone deacetylase 6
Beate König, P. R. Watson, Nina Reßing, et al.
(2023)
Open Access | Times Cited: 1
Biological and structural investigation of tetrahydro-β-carboline-based selective HDAC6 inhibitors with improved stability
Simon Scheuerer, L. Motlova, Linda Schäker‐Hübner, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116676-116676
Open Access
Synergizing GA-XGBoost and QSAR Modeling: Breaking Down Activity Cliffs in HDAC1 Inhibitors
Rahul D. Jawarkar, Suraj N. Mali, Prashant K. Deshmukh, et al.
Journal of Molecular Graphics and Modelling (2024) Vol. 135, pp. 108915-108915
Closed Access
The proteolytic cleavage of TLR8 Z-loop by furin protease - molecular recognition, reaction mechanism and role of water molecules
Maria Bzówka, Katarzyna Szleper, Agnieszka Stańczak, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top